Skip to content
Omnikalc

CHA₂DS₂-VASc score calculator: stroke risk in atrial fibrillation

Calculate the CHA₂DS₂-VASc score and the newer CHA₂DS₂-VA score used to estimate stroke risk and discuss anticoagulation in atrial fibrillation.

Updated on
Your inputs
years

Value out of range

Sex
Heart failure (C)
Hypertension (H)
Diabetes (D)
Prior stroke, TIA or thromboembolism (S₂)
Vascular disease: heart attack, peripheral artery disease or aortic plaque (V)

Results

CHA₂DS₂-VASc score

2

Higher risk Anticoagulation is generally recommended unless there is a contraindication.

CHA₂DS₂-VA score (2024 ESC guidelines)

2

Oral anticoagulation recommended
Points for age
1

Stroke risk in atrial fibrillation

Atrial fibrillation makes the upper chambers of the heart quiver instead of contracting, so blood can pool and clot. A clot that travels to the brain causes a stroke. Blood thinners (anticoagulants) cut that risk by about two thirds but increase the risk of bleeding. The CHA₂DS₂-VASc score helps decide who benefits enough to take one.

The points

Letter Risk factor Points
C Congestive heart failure 1
H Hypertension 1
A₂ Age 75 or older 2
D Diabetes 1
S₂ Prior stroke, TIA or thromboembolism 2
V Vascular disease (heart attack, peripheral artery disease, aortic plaque) 1
A Age 65 to 74 1
Sc Sex category: female 1

The maximum is 9 points.

Worked example

A 70-year-old man with atrial fibrillation and high blood pressure, without other risk factors.

  1. Hypertension: 1 point.
  2. Age 65 to 74: 1 point.
  3. CHA₂DS₂-VASc = 2, and CHA₂DS₂-VA = 2.

At 2 points in a man, current guidelines recommend oral anticoagulation unless bleeding risk or another reason argues against it.

What the score means

The 2023 ACC/AHA/ACCP/HRS guideline recommends anticoagulation when the yearly stroke risk is about 2% or more, which corresponds to a CHA₂DS₂-VASc of 2 or more in men and 3 or more in women. Anticoagulation is reasonable at 1 in men and 2 in women. At 0 in men or 1 in women, it is generally not needed.

CHA₂DS₂-VA

The 2024 European Society of Cardiology guidelines dropped the point for female sex, because female sex mainly amplifies risk in the presence of other factors. The resulting CHA₂DS₂-VA score recommends anticoagulation from 2 points and suggests considering it at 1. The calculator shows both scores side by side.

Practical points

  • The score does not apply to atrial fibrillation with moderate to severe mitral stenosis or a mechanical valve: those patients need anticoagulation regardless.
  • Bleeding risk is assessed separately, and modifiable bleeding risks such as uncontrolled blood pressure or NSAID use should be corrected rather than used as a reason to withhold treatment.
  • Aspirin alone is no longer recommended for stroke prevention in atrial fibrillation.
  • Recalculate the score over time: turning 65 or 75, or a new diagnosis of diabetes, can change the recommendation.

This calculator is for general information and education. It is not medical advice and does not replace the judgment of a doctor, nurse or pharmacist who knows the full clinical picture.

Frequently asked questions

What does CHA₂DS₂-VASc stand for?

Congestive heart failure, Hypertension, Age 75 or older (2 points), Diabetes, prior Stroke or TIA (2 points), Vascular disease, Age 65 to 74, and Sex category (female).

When is anticoagulation recommended?

US guidelines recommend it for a score of 2 or more in men and 3 or more in women, and consider it reasonable at 1 in men or 2 in women. The decision weighs stroke risk against bleeding risk.

What is the CHA₂DS₂-VA score?

The version adopted by the 2024 European (ESC) guidelines, which drops the point for female sex. Anticoagulation is recommended from 2 points and should be considered at 1.

Does the score apply to every atrial fibrillation patient?

No. It is not used for atrial fibrillation with moderate to severe mitral stenosis or a mechanical heart valve, where anticoagulation is indicated regardless of the score.

Was this calculator helpful?

Thanks for your feedback!

Results are estimates provided for information purposes. They do not replace professional advice.